Issue 4/2006
Content (14 Articles)
Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules
Koji Tamada, Lieping Chen
Structure and function of ETAA16: a novel cell surface antigen in Ewing’s tumours
A. Borowski, U. Dirksen, L. Lixin, R. L. Shi, U. Göbel, E. M. Schneider
Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro
Su-Ping Ren, Chu-Tse Wu, Wen-Rong Huang, Zhuo-zhuang Lu, Xiang-Xu Jia, Lan Wang, Miao-Fen Lao, Li-Sheng Wang
Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR
Bing Hu, Yu-quan Wei, Ling Tian, Xia Zhao, You Lu, Yang Wu, Bing Yao, Xiao-wei Zhang
Interferon-α/β upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-α/β treatment
Kouzaburo Yamaji, Shigeki Nabeshima, Masayuki Murata, Yong Chong, Norihiro Furusyo, Hideyuki Ikematsu, Jun Hayashi
Efficacy of adjuvant Immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials
Junichi Sakamoto, Satoshi Morita, Koji Oba, Takanori Matsui, Michiya Kobayashi, Hiroaki Nakazato, Yasuo Ohashi
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice
Dean Johnston, Sandra R. Reynolds, Jean-Claude Bystryn
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
Erin Gatza, Craig Y. Okada
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
A.N. Alexander, M.K. Huelsmeyer, Ann Mitzey, R.R. Dubielzig, I.D. Kurzman, E.G. MacEwen, D.M. Vail
Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells
Joel de Leòn, Audry Fernández, Circe Mesa, Marilyn Clavel, Luis E. Fernández
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients
J. B. A. G. Haanen, A. Baars, R. Gomez, P. Weder, M. Smits, T. D. de Gruijl, B. M. E. von Blomberg, E. Bloemena, R. J. Scheper, S. M. van Ham, H. M. Pinedo, A. J. M. van den Eertwegh
Importance of signaling via the IFN-α/β receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor
Margalit B. Mokyr, Aaron T. Place, James E. Artwohl, VE Ted Valli
A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients
Myrto Trakatelli, Michel Toungouz, Didier Blocklet, Ygierne Dodoo, Laurence Gordower, Marianne Laporte, Pierre Vereecken, Francois Sales, Laurent Mortier, Naima Mazouz, Micheline Lambermont, Serge Goldman, Pierre Coulie, Michel Goldman, Thierry Velu
Cancer Immunotherapy 2005: Mainz, Germany, 12–13 May 2005
C. M. Britten, C. Gouttefangeas, S. Kreiter